Head and neck oncology is one of the main clinical and research fields in our department. The management of head and neck cancer (HNC) involves the combined-modalities of chemotherapy, radiation therapy and surgery. At the same time, we are designing new treatments aimed at improving treatment outcomes and patients' quality of life and arepromoting clinical research into immunotherapy using NKT cells.
We are also devoting our efforts to develop new treatments in allergic diseases including immunotherapy, and our department is central to the research and treatment of allergic rhinitis (AR) in Japan.
|Associate Professors||Toyoyuki Hanazawa||Daijyu Sakurai|
|Staff||Hideaki Chazono||Kazuki Yamasaki|
|Naoki Kunii||Takeshi Suzuki|